Behzad Etemad

2.2k total citations
19 papers, 671 citations indexed

About

Behzad Etemad is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Behzad Etemad has authored 19 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 14 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Behzad Etemad's work include HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (11 papers) and HIV/AIDS drug development and treatment (10 papers). Behzad Etemad is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (11 papers) and HIV/AIDS drug development and treatment (10 papers). Behzad Etemad collaborates with scholars based in United States, Uganda and India. Behzad Etemad's co-authors include Jonathan Z. Li, Daniel R. Kuritzkes, S. Swaminathan, Hayat Ahmed, Evgenia Aga, John W. Mellors, Navin Khanna, Ronald J. Bosch, Rajesh T. Gandhi and Michael F. Para and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Journal of Virology.

In The Last Decade

Behzad Etemad

19 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Behzad Etemad United States 13 412 397 134 127 118 19 671
Sandhya Vasan United States 16 405 1.0× 390 1.0× 212 1.6× 447 3.5× 64 0.5× 60 998
Milena Veselinović United States 8 296 0.7× 122 0.3× 96 0.7× 64 0.5× 267 2.3× 11 534
Merle Schanz Switzerland 9 164 0.4× 231 0.6× 237 1.8× 152 1.2× 25 0.2× 12 569
Chitra Upadhyay United States 14 215 0.5× 142 0.4× 88 0.7× 101 0.8× 44 0.4× 30 400
S Conley United States 8 244 0.6× 463 1.2× 120 0.9× 199 1.6× 33 0.3× 9 553
Haili Tang United States 12 452 1.1× 447 1.1× 157 1.2× 271 2.1× 19 0.2× 21 786
Heather Vinet-Oliphant United States 8 230 0.6× 119 0.3× 56 0.4× 131 1.0× 188 1.6× 9 442
Nicholas Francella United States 11 137 0.3× 128 0.3× 116 0.9× 127 1.0× 40 0.3× 12 411
Deena Ratner United States 13 248 0.6× 337 0.8× 174 1.3× 165 1.3× 37 0.3× 22 665
Julie A. Waterbury United States 6 405 1.0× 604 1.5× 226 1.7× 194 1.5× 23 0.2× 6 767

Countries citing papers authored by Behzad Etemad

Since Specialization
Citations

This map shows the geographic impact of Behzad Etemad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behzad Etemad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behzad Etemad more than expected).

Fields of papers citing papers by Behzad Etemad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behzad Etemad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behzad Etemad. The network helps show where Behzad Etemad may publish in the future.

Co-authorship network of co-authors of Behzad Etemad

This figure shows the co-authorship network connecting the top 25 collaborators of Behzad Etemad. A scholar is included among the top collaborators of Behzad Etemad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behzad Etemad. Behzad Etemad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Etemad, Behzad, Christy L. Lavine, Yijia Li, et al.. (2023). Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption. Science Translational Medicine. 15(695). eabq4490–eabq4490. 12 indexed citations
2.
Li, Yijia, Sushama Telwatte, Meghan Melberg, et al.. (2022). Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control. Journal of Virology. 97(1). 7 indexed citations
3.
Giron, Leila B., Clovis S. Palmer, Qin Liu, et al.. (2021). Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nature Communications. 12(1). 3922–3922. 37 indexed citations
4.
Li, Yijia, Behzad Etemad, Radwa Sharaf, et al.. (2021). Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation. AIDS. 35(7). 1015–1020. 15 indexed citations
5.
Etemad, Behzad, et al.. (2019). Learning From the Exceptions: HIV Remission in Post-treatment Controllers. Frontiers in Immunology. 10. 1749–1749. 33 indexed citations
6.
Park, You Jeong, Behzad Etemad, Hayat Ahmed, et al.. (2017). Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption. SHILAP Revista de lepidopterología. 2(3). 431–431. 10 indexed citations
7.
Kanakasabapathy, Manoj Kumar, Hardik J. Pandya, Mohamed S. Draz, et al.. (2017). Rapid, label-free CD4 testing using a smartphone compatible device. Lab on a Chip. 17(17). 2910–2919. 62 indexed citations
8.
Lin, Nina, Behzad Etemad, Hong Lü, et al.. (2016). Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants. EBioMedicine. 8. 237–247. 14 indexed citations
9.
Tang, Jonathan C. Y., Eugene Drokhlyansky, Behzad Etemad, et al.. (2016). Detection and manipulation of live antigen-expressing cells using conditionally stable nanobodies. eLife. 5. 66 indexed citations
10.
Li, Jonathan Z., Behzad Etemad, Hayat Ahmed, et al.. (2015). The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS. 1–1. 189 indexed citations
11.
Etemad, Behzad, et al.. (2015). Single genome amplification and standard bulk PCR yield HIV-1 envelope products with similar genotypic and phenotypic characteristics. Journal of Virological Methods. 214. 46–53. 11 indexed citations
12.
Etemad, Behzad, Laura F. White, Oliver Laeyendecker, et al.. (2014). Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users. Retrovirology. 11(1). 106–106. 12 indexed citations
13.
Peña‐Cruz, Victor, Behzad Etemad, Nikolaos Chatziandreou, et al.. (2013). HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partners. Retrovirology. 10(1). 162–162. 14 indexed citations
14.
Etemad, Behzad, et al.. (2013). Early Infection HIV-1 Envelope V1-V2 Genotypes Do Not Enhance Binding or Replication in Cells Expressing High Levels of α4β7 Integrin. JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(3). 249–253. 6 indexed citations
15.
16.
Etemad, Behzad, Andrew D. Redd, David Serwadda, et al.. (2012). Envelopes found early after acquisition compared to those in the chronically infected partner do not have enhanced alpha4 beta7 binding or utilization. Retrovirology. 9(S2). 1 indexed citations
17.
Etemad, Behzad, Brenda Kwambana-Adams, Anupa Kamat, et al.. (2009). Human Immunodeficiency Virus Type 1 V1-to-V5 Envelope Variants from the Chronic Phase of Infection Use CCR5 and Fuse More Efficiently than Those from Early after Infection. Journal of Virology. 83(19). 9694–9708. 33 indexed citations
18.
Etemad, Behzad, Gaurav Batra, Rajendra Raut, et al.. (2008). An Envelope Domain III–based Chimeric Antigen Produced in Pichia pastoris Elicits Neutralizing Antibodies Against All Four Dengue Virus Serotypes. American Journal of Tropical Medicine and Hygiene. 79(3). 353–363. 73 indexed citations
19.
Etemad, Behzad, et al.. (2006). INDUCTION OF NEUTRALIZING ANTIBODIES SPECIFIC TO DENGUE VIRUS SEROTYPES 2 AND 4 BY A BIVALENT ANTIGEN COMPOSED OF LINKED ENVELOPE DOMAINS III OF THESE TWO SEROTYPES. American Journal of Tropical Medicine and Hygiene. 74(2). 266–277. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandhya Vasan Breakdown of academic impact, for papers by Milena Veselinović Breakdown of academic impact, for papers by Merle Schanz Breakdown of academic impact, for papers by Chitra Upadhyay Breakdown of academic impact, for papers by S Conley Breakdown of academic impact, for papers by Haili Tang Breakdown of academic impact, for papers by Heather Vinet-Oliphant Breakdown of academic impact, for papers by Nicholas Francella Breakdown of academic impact, for papers by Deena Ratner Breakdown of academic impact, for papers by Julie A. Waterbury
Rankless by CCL
2026